A UK Real-world Evaluation of Efficacy and Toxicity of Second-line Trastuzumab Emtansine and Third-line Trastuzumab Deruxtecan in HER2-positive Advanced Breast Cancer. - Peters, S.; Tang, H.C.; Shafiq, T.; Karim, S.; Khan, S.; Trivedi, S.; Anand, A.; Sheikh, H.B.; Saghir, S.; Lui, J.; Prabhu, D.S.; Mathew, T.; et al. (Clinical Oncology, 2023)